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he function of the nonreceptor tyrosine kinase c-Src as
a plasma membrane–associated molecular effector of a
variety of extracellular stimuli is well known. Here, we
show that c-Src is also present within mitochondria, where it
 
phosphorylates cytochrome
 
 c
 
 oxidase (Cox). Deleting the
 
c-
 
src
 
 gene reduces Cox activity, and this inhibitory effect
is restored by expressing exogenous c-Src. Furthermore,
reducing endogenous Src kinase activity down-regulates
Cox activity, whereas activating Src has the opposite effect.
T
 
Src-induced Cox activity is required for normal function of
cells that require high levels of ATP, such as mitochondria-
rich osteoclasts. The peptide hormone calcitonin, which
inhibits osteoclast function, also down-regulates Cox activity.
Increasing Src kinase activity prevented the inhibitory effect
of calcitonin on Cox activity and osteoclast function. These
results suggest that c-Src plays a previously unrecognized
role in maintaining cellular energy stores by activating Cox
in mitochondria.
 
Introduction
 
The nonreceptor tyrosine kinase c-Src, which is highly con-
served throughout evolution and widely expressed, is a member
of a family of nine protein tyrosine kinases that associate with
the cytoplasmic surface of cellular membranes (Brown and
Cooper, 1996). It is generally thought that Src’s regulation of
cell adhesion, movement, and proliferation involves its activity
as a plasma membrane–associated molecular switch that links
a variety of extracellular cues to specific intracellular signaling
pathways (Thomas and Brugge, 1997). c-Src has also been
reported to be present on late endosomes in fibroblasts (Kaplan
et al., 1992), synaptic vesicles in PC12 cells (Linstedt et al.,
1992), secretory vesicles in chromaffin cells (Grandori and
Hanafusa, 1988), vesicular structures in osteoclasts (Horne et
al., 1992; Tanaka et al., 1996), and the Golgi apparatus in
CHO cells (Bard et al., 2002). More recently, Lyn, another
Src family kinase, was found in rat brain mitochondria (Salvi
et al., 2002). However, the functions of c-Src on intracellular
membranes still remain to be determined.
In aerobic conditions, most of the energy produced by
 
eukaryotic cells is in the form of ATP generated by mito-
chondrial oxidative phosphorylation, a process in which
electrons are passed along a series of carrier molecules called
the electron transport chain. These electrons are initially
 
generated from NADH and FADH
 
2
 
, which are produced by
the metabolism of nutrients such as glucose, and are ultimately
transferred to molecular oxygen. The electron transport
chain consists of four respiratory enzyme complexes. Cyto-
 
chrome 
 
c
 
 oxidase (Cox),* which contains 13 subunits, is the
terminal oxidase of cell respiration. The three major sub-
units of Cox are encoded by mitochondrial DNA and form
the functional core of the enzyme; this core is surrounded
by 10 nuclear-coded small subunits. Cox reduces dioxygen
 
to water with four electrons from cytochrome 
 
c
 
 and four
protons taken up from the mitochondrial matrix, without
the formation of reactive oxygen species. The energy gener-
ated by the passage of electrons down the electron transport
chain creates a proton gradient across the membrane that
drives ATP synthase to make ATP from ADP. The synthesized
ATP is used for energy-requiring reactions in the matrix,
and is exported to the cytosol by the adenine nucleotide
translocator in exchange for cytosolic ADP (Wallace, 1999;
van den Heuvel and Smeitink, 2001). Although osteoclasts
contain large numbers of mitochondria, the regulation of
their functioning has not been characterized.
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*Abbreviations used in this paper: Cox, cytochrome
 
 c
 
 oxidase; Csk, COOH-
 
terminal Src family kinase; CT, calcitonin; ERK, extracellular signal-
regulated kinase; MEK, MAPK/ERK kinase; MOI, multiplicity of infection;
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Here, we show that c-Src is located within mitochondria
and that it modulates Cox. Using mitochondria-rich osteo-
clasts as a model system, we investigated the physiological
significance of the regulation of Cox by c-Src and found that
Src-induced Cox activity is important for normal function
of osteoclasts.
 
Results
 
c-Src is associated with mitochondria
 
Recently, Lyn, another Src family kinase, was found in rat
brain mitochondria (Salvi et al., 2002). To examine whether
or not c-Src is also located in mitochondria, organelles from
HEK 293 cells were separated by ultracentrifugation on Op-
tiPrep™ discontinuous gradients. The fractions were West-
ern blotted using anti-Src and organelle-specific antibodies,
including anti-Golgi 58K protein (Golgi complex), anti-
EEA1 (early endosome), anti-calnexin (ER), anti-cathepsin
D (lysosome), and anti-Cox subunit Vb (CoxVb; mitochon-
dria; Fig. 1 A). A plasma membrane marker, PMCA (plasma
membrane Ca
 
2
 
 
 
 ATPase), was found in the lighter fractions
1–3. The Golgi complex and early endosomes had a wide
range of distribution, in fractions 1–5 and 2–7, respectively.
ER and lysosomes were found in fractions 3–6 and 6–8, re-
spectively. Mitochondria were mainly in the more dense
fractions 8–9. Src was detected in all fractions, suggesting
that it associates with various intracellular membranes, in-
cluding mitochondria.
To examine whether Src is located inside or outside the
mitochondria, we next assessed the sensitivity of the mito-
chondria-associated Src to proteinase K. For this experi-
ment, the freshly prepared mitochondrial fraction was incu-
bated with proteinase K in the absence or presence of Triton
X-100, and the mitochondrial proteins were Western blot-
ted for Src, Bcl-2, and CoxVb. As shown in Fig. 1 B,
CoxVb, which is located inside the mitochondria, was fully
protected from proteinase K in the absence of detergent,
whereas Bcl-2, which is associated with the external mito-
chondrial membrane, was completely degraded regardless of
whether Triton X-100 was present or not. Interestingly, a
significant fraction of Src was not degraded by proteinase K
in the absence of Triton X-100, suggesting that some Src is
located inside the mitochondria.
To confirm these biochemical results, we used immuno-
electron microscopy to directly visualize c-Src in mitochon-
dria. As shown in Fig. 1 C, c-Src was associated with the in-
ner mitochondrial membrane. As positive control, we used
an antibody against the membrane-bound Cox subunit IV
(CoxIV). In contrast, no mitochondria showed labeling in
the absence of the c-Src antibody (negative control).
To further confirm the specificity of the immunogold la-
beling, we used mitochondria-enriched preparations from
c-Src
 
 
 
/?
 
 and c-Src
 
 
 
/
 
 
 
 osteoclast-like cells (OCLs). As shown
in Fig. 1 D, c-Src was also located inside mitochondria of
c-Src
 
 
 
/?
 
 OCLs, whereas no labeling was seen in the mito-
chondria of c-Src
 
 
 
/
 
 
 
 OCLs.
 
c-Src phosphorylates Cox
 
Mitochondria were isolated from c-Src–overexpressing HEK
293 cells, and the mitochondrial proteins were separated on
two-dimensional nondenaturing/denaturing gels (2-D gels).
Western blots of the mitochondrial proteins suggested that
one of the tyrosine-phosphorylated mitochondrial proteins
was the Cox subunit II (CoxII; Fig. 2 A). To determine di-
rectly whether Src can phosphorylate CoxII, immunoprecip-
itated CoxII and the total mitochondrial fraction (MT) were
Western blotted with anti-phosphotyrosine and anti-CoxII
antibodies. Transfection of cells with c-Src resulted in in-
creased tyrosine phosphorylation of CoxII (Fig. 2 B). Src
could be phosphorylating CoxII directly, or it could be
acting indirectly through Src-activated pathways involving
other kinase(s). To distinguish between these two possibili-
ties, in vitro kinase assays were performed using purified
c-Src and CoxII. Immunoprecipitated CoxII was incubated
Figure 1. c-Src localization in subcellular fractions and purified 
mitochondria. (A) Subcellular fractionation of homogenized HEK 
293 cells. Cell membranes were fractionated by centrifugation on 
discontinuous OptiPrep™ gradients, and the resulting fractions 
were immunoblotted with anti-PMCA, anti-Golgi 58K, anti-EEA1, 
anti-calnexin, anti-cathepsin D, anti-CoxVb, and anti-Src antibodies. 
(B) The mitochondrial fraction was isolated as described in Materials 
and methods and treated with 50 ng/ml proteinase K (PK) in the 
absence or presence of 0.5% Triton X-100 (TX) at RT for 30 min. 
The reaction was analyzed by Western blotting using antibodies to 
c-Src, Bcl-2, and CoxVb. (C) Immunogold labeling of c-Src in isolated 
mitochondria from HEK 293 cells. As positive control, CoxIV antibody 
was used for the primary antibody. As negative control (NC), gold-
labeled secondary antibody was applied in the absence of c-Src 
antibody. (D) Immunogold labeling of c-Src in isolated mitochondria 
from c-Src
 /? and c-Src
 /  OCLs. c-Src was associated with the inner 
mitochondrial membrane in c-Src
 /? OCLs, whereas no labeling was 
detected in the mitochondria of c-Src
 /  OCLs.T
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with purified c-Src in kinase buffer containing 
 
 
 
[
 
32
 
P]ATP.
Enolase was used as a positive control. The reaction was sub-
jected to SDS-PAGE and the phosphorylation analyzed by
autoradiography. The results (Fig. 2 C) showed that c-Src
could phosphorylate CoxII directly.
 
Cox activity is down-regulated by c-Src deficiency
 
To examine the functional consequences of the tyrosine phos-
phorylation of Cox by Src, we investigated whether or not Src
kinase activity affected Cox activity. For this purpose, we used
Src family tyrosine kinase–deficient mouse embryonic fibro-
blasts (Klinghoffer et al., 1999). As shown in Fig. 3 A, Cox ac-
tivity in Src
 
 
 
/
 
 
 
 Yes
 
 
 
/
 
 
 
 Fyn
 
 
 
/
 
 
 
 cells (SYF) was significantly
decreased compared with Yes
 
 
 
/
 
 
 
 Fyn
 
 
 
/
 
 
 
 cells (Src
 
  
 
). Fur-
thermore, reintroduction of c-Src into SYF cells (c-Src) re-
stored Cox activity to the higher level of Src
 
  
 
 cells (Fig. 3
A). In contrast, there was no significant difference of complex
I (NADH:ubiquinone oxidoreductase) activity among these
cell types (Fig. 3 B). These results suggest that Src promotes
Cox activity in mouse embryonic fibroblasts.
If c-Src promotes Cox activity under physiological condi-
tions, one would predict that Cox activity would be lower in
mitochondria from c-Src
 
 
 
/
 
 
 
 animals. Therefore, we isolated
mitochondria from several tissues of c-Src
 
 
 
/?
 
 and c-Src
 
 
 
/
 
 
 
mice (liver, kidney, and muscle) and assayed Cox activity. As
shown in Fig. 3 C, Cox activity in mitochondria from liver
and kidney were significantly decreased when Src was ab-
sent. In contrast, there was little difference in mitochondria
from muscle, possibly due to relatively lower levels of expres-
sion of c-Src or to complete compensation by other Src fam-
ily members.
 
Cox activity is positively correlated 
with c-Src kinase activity
 
To examine the physiological significance of the up-regula-
tion of Cox by Src, we selected osteoclasts as a model system.
Osteoclasts, the multinucleated giant cells responsible for
bone resorption, have large numbers of mitochondria and
express high levels of c-Src (Horne et al., 1992; Tanaka et
al., 1992; Baron et al., 1993), and high levels of ATP are re-
Figure 2. Phosphorylation of Cox by c-Src. (A) Immunodetection 
of phosphotyrosine and Cox subunits in mitochondria from c-Src–
overexpressing HEK 293 cells analyzed by two-dimensional 
electrophoresis. Mitochondrial proteins were separated in the 
first dimension by nondenaturing Blue-native PAGE and in the 
second dimension by SDS-PAGE, and were then transferred to 
nitrocellulose membranes. Membranes were immunoblotted with 
anti-phosphotyrosine (p-Tyr) antibody, then stripped, cut in three 
parts at the dotted lines, and reprobed with antibody to Cox subunits. 
The position of CoxI, CoxII, and CoxVb are indicated on the right. 
(B) Tyrosine phosphorylation of CoxII in HEK 293 cells with or without 
transfected c-Src expression vector. Endogenous CoxII protein was 
immunoprecipitated, and Western blotting was performed with 
anti-phosphotyrosine antibody. The membrane was then reprobed 
with anti-CoxII antibody. MT, total mitochondrial fraction. (C) Enolase 
and CoxII were incubated with c-Src in kinase buffer containing 
 [
32P]ATP at 30 C for 20 min. Positions of c-Src, enolase, and CoxII 
are indicated on the left.
Figure 3. Cox activity in c-Src–deficient cells. (A) Cox activity in 
cells expressing endogenous Src (Src  ), SYF cells (SYF), and SYF 
cells transfected with c-Src (c-Src) was measured by determining the 
increase in OD (450 nm) as described in Materials and methods. 
The values are means   SD (n   8; *, P   0.05 compared with 
Src   cells; **, P   0.01). (B) Complex I (NADH:ubiquinone 
oxidoreductase) activity in cells expressing endogenous Src (Src  ), 
SYF cells (SYF), and SYF cells transfected with c-Src (c-Src). No 
significant difference was found. The values are means   SD 
(n   8). (C) Cox activity of liver, kidney, and muscle in c-Src
 /? and 
c-Src
 /  mice. The values are means   SD (n   8; **, P   0.01 
compared with c-Src
 /? OCLs).T
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quired to support acid secretion by the osteoclast V-ATPase
as well as other functions that are required for bone resorp-
tion (Baron et al., 1993).
Two-dimensional gel analysis showed that CoxII in the
mitochondria from the murine c-Src
 
 
 
/?
 
 OCLs was tyrosine-
phosphorylated as had been observed in the mitochondria
from the human cell line. Interestingly, CoxI was also tyro-
sine-phosphorylated. Much less tyrosine phosphorylation of
these proteins was observed in mitochondria from c-Src
 
 
 
/
 
 
 
OCLs (Fig. 4 A), although the low level of residual tyrosine
phosphorylation suggests that other Src family tyrosine ki-
nase may also phosphorylate Cox subunits.
Cox activity was reduced in c-Src
 
 
 
/
 
 
 
 OCLs formed in
vitro (Fig. 4 B), as it had been in fibroblasts that lack multi-
ple the Src family tyrosine kinases and in the liver and kid-
 
ney from the c-Src
 
 
 
/
 
 
 
 mice, further indicating that Src reg-
ulates Cox activity. To test whether modulating Src kinase
activity in OCLs would affect Cox activity and cell function
(i.e., bone resorption), we used adenovirus vectors contain-
ing kinase-dead c-Src (AxSrc
 
KD
 
), wild-type COOH-termi-
nal Src family kinase (AxCsk
 
WT
 
), or kinase-dead Csk
(AxCsk
 
KD
 
). Wild-type Csk phosphorylates the negative reg-
ulatory site (Tyr-527) of c-Src (Nada et al., 1991), inhibit-
ing Src activity. Conversely, Csk
 
KD
 
 acts as a dominant-neg-
ative molecule against endogenous Csk, increasing Src
kinase activity and bone-resorbing activity in osteoclasts
(Miyazaki et al., 2000a). As predicted, down-regulation of
Src kinase activity by Src
 
KD
 
 or Csk
 
WT
 
 overexpression inhib-
ited Cox activity in OCLs, whereas up-regulation of Src ki-
nase activity by AxCsk
 
KD
 
 infection induced higher Cox
activity (Fig. 4 C). Thus, Cox activity was positively corre-
lated with Src kinase activity.
 
Cox activity contributes to osteoclast function
 
To determine if reducing Cox activity affects the bone-re-
sorbing activity of OCLs, we took advantage of the fact that
the nuclear-encoded Cox subunit IV (CoxIV) is absolutely
required for Cox activity (Burke and Poyton, 1998). OCLs
were infected with an adenovirus vector carrying CoxIV an-
tisense (AxCoxIV
 
AS
 
). The adenovirus vector that encodes
GFP (AxGFP) was used as a control vector. The expression
of CoxIV in OCLs infected with AxCoxIV
 
AS
 
 decreased in a
multiplicity of infection (MOI)-dependent manner (Fig. 5
A). The decreasing levels of CoxIV correlated with decreased
Cox activity in a biochemical assay; OCLs infected with Ax-
CoxIV
 
AS
 
 at an MOI of 100 showed 45% of basal Cox activ-
ity (Fig. 5 B). As shown in Fig. 5 C, there was no significant
change in Src kinase activity among OCLs infected with
AxGFP or AxCoxIV
 
AS
 
.
Osteoclasts adhere to the bone surface through specialized
discrete structures in the clear zone called “podosomes,”
which are punctate structures containing short actin fila-
ments and numerous associated proteins. The ring of podo-
somes, also referred to as the actin ring, is a characteristic of
polarized osteoclasts. There was no morphological difference
between uninfected OCLs and AxGFP-infected OCLs (un-
published data). As shown in the left panel of Fig. 5 D, tar-
trate-resistant acid phosphatase (TRAP)-stained OCLs in-
fected with AxCoxIV
 
AS
 
 had an elongated shape rather than
the typical rounded appearance of wild-type osteoclasts. To
determine whether AxCoxIV
 
AS
 
 infection modulates the cy-
toskeletal organization of osteoclasts, F-actin was stained
with rhodamine-conjugated phalloidin (Fig. 5 D). An actin
ring was observed in 
 
 
 
85% of the AxGFP-infected OCLs,
whereas only 15% of OCLs infected with AxCoxIV
 
AS
 
formed these rings. Consistent with the absence of the actin
ring, bone-resorbing activity was progressively and severely
inhibited as the MOI of AxCoxIV
 
AS
 
 increased (Fig. 5 E).
Thus, basal Cox activity is required for normal bone resorp-
tion, consistent with the high ATP requirement of the
V-ATPase and other ATP-dependent activities of resorbing
osteoclasts. The inhibitory effect of AxCoxIV
 
AS
 
 on bone re-
sorption was not reversed by Csk
 
KD
 
 overexpression (Fig. 5
G), even though c-Src kinase activity was increased in OCLs
coinfected with AxCoxIV
 
AS
 
 and AxCsk
 
KD
 
 as much as it was
Figure 4. c-Src kinase activity modulates Cox activity in osteoclasts. 
(A) Immunodetection of phosphotyrosine and Cox subunits in 
mitochondria from c-Src
 /? and c-Src
 /  OCLs analyzed by two-
dimensional electrophoresis. Membranes were immunoblotted with 
anti-phosphotyrosine (p-Tyr) antibody, then stripped, cut in three 
parts at the dotted lines, and reprobed with antibody to Cox subunits. 
Although the CoxII antibody did not recognize mouse CoxII, we can 
identify CoxII in the 2-D gel by its relative mobility. The position of 
CoxI, CoxII, and CoxVb are indicated. (B) Cox activity in c-Src
 /? 
and c-Src
 /  OCLs. The values are means   SD (n   8; *, P   0.01 
compared with uninfected OCLs). (C) Cox activity in OCLs infected 
with AxGFP, AxSrc
KD, AxCsk
WT, or AxCsk
KD at an MOI of 100. 
The values are means   SD (n   8; *, P   0.01 compared with 
uninfected OCLs).T
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in OCLs infected with AxCsk
KD alone (Fig. 5 F). Together,
these results indicate that Cox is a downstream effector of
Src and that it is required in order for osteoclast function to
proceed normally.
Down-regulation of Cox activity 
does not affect the survival of OCLs
Inhibition of Cox can lead to the release of cytochrome c
from mitochondria into the cytoplasm (Yang et al., 1998),
which in turn activates a signaling cascade that ultimately
cleaves and activates caspase-3, causing apoptosis (Liu et al.,
1996; Kluck et al., 1997; Li et al., 1997). Therefore, it is
possible that the CoxIV
AS-induced decrease in Cox activity
increased OCL apoptosis, with accompanying disorganiza-
tion of the cytoskeleton and decreased bone-resorbing activ-
ity. To address this question, we used a nucleic acid stain to
visualize the morphology of nuclei. The nuclei of OCLs in-
fected with AxCoxIV
AS were stained uniformly with TO-
Figure 5. CoxIV antisense prevents bone resorption in a dose-dependent manner. (A) OCLs were infected with AxGFP or AxCoxIV
AS at the 
indicated MOIs. Membranes were immunoblotted with anti-CoxIV antibody, then stripped and reprobed with anti-actin antibody. (B) Cox 
activity in OCLs infected with AxGFP or AxCoxIV
AS at the indicated MOIs. Cox activity of the cells was measured as described in Materials 
and methods. The values are means   SD (n   8; *, P   0.01 compared with uninfected OCLs). (C) c-Src kinase activity in OCLs infected 
with AxGFP or AxCoxIV
AS at the indicated MOIs was assayed by in vitro kinase assay using enolase as a substrate. (D) Effects of AxCoxIV
AS on 
osteoclast morphology. Co-cultures infected with AxGFP or AxCoxIV
AS at an MOI of 100 were plated on serum-coated glass coverslips for 
12 h and then costained for TRAP activity (left) and for F-actin using rhodamine phalloidin (right). (E) Dentine-resorbing activity of OCLs 
expressing CoxIV antisense (AxCoxIV
AS). An aliquot of the OCL preparation was transferred to dentine and cultured for an additional 12 h. 
The resorbed area on the dentine slices was measured as described in Materials and methods. The values are means   SD (n   8; *, P   0.01 
compared with uninfected OCLs). (F) OCLs infected with both AxCsk
KD and AxCoxIV
AS expressed Csk and CoxIV at levels similar to those 
of the cells infected with either AxCsk
KD or AxCoxIV
AS alone. c-Src kinase activity in OCLs coinfected with AxCsk
KD and AxCoxIV
AS was 
measured by in vitro kinase assay using enolase as a substrate. (G) Dentine-resorbing activity of OCLs coinfected with AxCsk
KD and AxCoxIV
AS. 
An aliquot of the OCL preparation was transferred onto dentine and cultured for an additional 12 h. The values are means   SD (n   8; 
*, P   0.01 compared with AxGFP-infected OCLs).T
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PRO
®-3 (Fig. 6 A), suggesting that the disruption of cyto-
skeleton by AxCoxIV
AS was not due to apoptosis. Next, we
investigated the survival of AxCoxIV
AS-infected OCLs, both
in the presence of osteoblastic cells, which promote OCL
survival by secreting M-CSF, RANK ligand, and other fac-
tors, and in their absence, where OCLs become apoptotic
and die within 24 h. There was no significant difference in
the survival of AxGFP-infected OCLs and AxCoxIV
AS-
infected OCLs either in the presence of osteoblastic cells
(unpublished data) or in their absence (Fig. 6 D). Thus, re-
ducing Cox activity to less than half of the normal level (Fig.
5 B) does not affect osteoclast survival under either condi-
tion, and the CoxIV
AS-induced changes in cytoskeletal orga-
nization and decreased bone-resorbing activity are not due
to increased apoptosis.
Previously, we have reported that extracellular signal–
related kinase (ERK) activation by constitutively active
MAPK/ERK kinase 1 (MEK
CA) expression strongly pro-
motes osteoclast survival (Miyazaki et al., 2000b). There-
fore, we investigated the survival of OCLs coinfected with
AxCoxIV
AS and AxMEK
CA, which expressed CoxIV and
MEK at levels similar to the cells infected with either Ax-
CoxIV
AS or AxMEK
CA (Fig. 6 B). 18 h after purification,
the level of proteolyzed caspase-3 had increased spontane-
ously in OCLs infected with AxGFP, and AxCoxIV
AS in-
fection further increased the amount of the active caspase-3
subunit in OCLs (Fig. 6 C). The infection with AxMEK
CA
markedly reduced the amount of active caspase-3 in both
AxGFP- and AxCoxIV
AS-infected cells. Consistent with
this result, the expression of MEK
CA promoted the survival
of OCLs coinfected with AxCoxIV
AS (Fig. 6, D and E).
The coinfected OCLs did not display the typical rounded
appearance of mature osteoclasts (Fig. 6 E). These data fur-
ther indicate that the down-regulation of osteoclast func-
tion by AxCoxIV
AS is mostly due to factors other than in-
creased apoptosis.
Calcitonin down-regulates Cox activity in OCLs
Calcitonin (CT) is a 32-amino acid polypeptide hormone
that inhibits osteoclastic bone resorption in a cAMP-depen-
dent manner (Nicholson et al., 1986). Because cAMP nega-
tively regulates Cox activity (Yang et al., 1998), we investi-
gated the effect of CT treatment on Cox activity in OCLs.
As shown in Fig. 7 A, CT induced a decrease in Cox activity
in OCLs, with the lowest level attained after 30 min of stim-
ulation. In contrast, c-Src kinase activity remained un-
changed after CT stimulation (Fig. 7 B). These results sug-
gest that Cox, but not c-Src, may play a role in CT-induced
inhibition of bone resorption.
Increasing c-Src kinase activity reverses the inhibitory 
effect of CT on bone resorption
Because c-Src kinase activity and CT treatment affect Cox
activity in osteoclasts in opposite ways, we examined the in-
teraction of c-Src and CT-induced signaling pathways in
the regulation of Cox. c-Src kinase activity was increased by
infecting OCLs with AxCsk
KD, and the effect of CT on Cox
activity and bone resorption was determined. Up-regulation
of Src kinase activity by AxCsk
KD reversed the CT-induced
inhibition of OCL Cox activity (Fig. 7 D), whereas increas-
ing Src kinase activity did not affect CT-induced cAMP
production (Fig. 7 C). Similarly, the dose-dependent inhi-
bition of the pit-forming activity by CT was largely pre-
vented by Csk
KD overexpression. In the presence of 10
 9 M
CT, which almost completely inhibited pit formation by
AxGFP-infected cells, the bone-resorbing activity of Ax-
Csk
KD-infected OCLs was almost as great as that of un-
treated AxGFP-infected OCLs (Fig. 7 E). Csk
KD expression
in OCLs also prevented the CT-induced disruption of actin
rings (Fig. 7 F). More than 80% of Csk
KD-expressing OCLs
still displayed the typical actin rings even after CT treat-
ment, whereas the disruption of actin ring formation was
observed in  80% of AxGFP-infected OCLs. Thus, c-Src
antagonizes CT-induced inhibition of both Cox activity
and bone resorption.
Figure 6. Infection with AxCoxIV
AS does not affect OCL survival. 
(A) Co-cultures infected with AxGFP or AxCoxIV
AS at an MOI of 100 
were plated on serum-coated glass coverslips for 12 h and then 
stained for F-actin using rhodamine phalloidin (red). To visualize the 
nuclei of the OCLs, the cells were stained with TO-PRO
®-3 (blue). 
Bars, 50  m. (B) OCLs coinfected with AxMEK
CA and AxCoxIV
AS 
at MOIs of 100 expressed the proteins at levels similar to the levels 
in the cells infected with either AxMEK
CA or AxCOxIV
AS alone. 
(C) Caspase-3 cleavage in OCLs infected with AxMEK
CA and/or 
AxCoxIV
AS. The time-dependent change in cleaved caspase-3 in 
purified OCLs was detected by Western blotting with anti-cleaved 
caspase-3 antibody. (D) Survival of OCLs infected with AxMEK
CA 
or/and AxCoxIV
AS. After purification, infected OCLs were incubated 
with  MEM/10% FBS for the indicated times. The number of viable 
cells remaining at the different time points is shown as a percentage of 
the number of cells at time 0. (E) Typical TRAP staining of OCLs 24 h 
after purification in the experiment quantified in (D). Bars, 100  m.T
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Discussion
The nonreceptor tyrosine kinase c-Src is a member of a fam-
ily of nine protein tyrosine kinases that associate with the cy-
toplasmic surface of the cellular membrane (Brown and
Cooper, 1996). Constitutively active mutants of Src are on-
cogenic, and study of these mutants has implicated c-Src in
the control of cell growth and proliferation. However, c-Src
is highly expressed in terminally differentiated cells such as
platelets, neurons, and osteoclasts, indicating a physiological
role for the protein unrelated to growth control. Targeted
disruption of the c-src gene in mice induces osteopetrosis, a
disorder characterized by decreased bone resorption, without
showing any obvious morphological or functional abnor-
malities in other tissues or cells (Soriano et al., 1991). Osteo-
clasts, which are responsible for bone resorption, express
high levels of c-Src protein, and c-Src–deficient osteoclasts
have impaired ability to form the actin ring (Boyce et al.,
1992). Together, these results indicate that c-Src plays an es-
sential role in the normal cellular function of osteoclasts.
c-Src is thought to be involved in intracellular signaling
pathways mainly as a plasma membrane–associated molecu-
lar effector of a variety of extracellular stimuli. c-Src has also
been reported to be present on some intracellular mem-
branes including late endosomes, the Golgi apparatus, and
vesicular structures (Grandori and Hanafusa, 1988; Horne
et al., 1992; Kaplan et al., 1992; Linstedt et al., 1992;
Tanaka et al., 1996; Bard et al., 2002). In this work, we
found that c-Src is also located within mitochondria, where
it appears to be associated with the inner membrane, in-
dicating that c-Src is imported from the cytosol into mi-
tochondria, not withstanding the absence of known mi-
tochondrial import motifs in c-Src. Furthermore, several
mitochondrial proteins were phosphorylated in c-Src–overex-
pressing HEK 293 cells and osteoclasts (Fig. 2 A and Fig. 4 A),
suggesting that c-Src–catalyzed tyrosine phosphorylation of mi-
tochondrial proteins, including Cox subunits, may regulates en-
ergy production by mitochondrial oxidative phosphorylation.
Our results support this hypothesis. c-Src deficiency re-
sults in decreased Cox activity in mouse embryonic fibro-
blasts, osteoclasts, and in several tissues. In addition, Cox
activity was also correlated with c-Src kinase activity,
decreasing when Src was down-regulated by the expression
of Csk
WT or the dominant-negative Src
KD, and increasing
when Src activity was up-regulated by the expression of
Csk
KD. Furthermore, we found that Cox activity was re-
quired for normal actin ring formation and bone-resorbing
activity of OCLs. Thus, normal osteoclast Cox activity is
important for both actin ring formation and bone resorp-
tion. The disruption of the actin ring could itself explain the
loss of bone-resorbing activity, although there are a number
of other ATP-dependent events, especially those involved in
cell motility, proton secretion, and the maintenance of elec-
trochemical homeostasis, that are necessary for normal os-
teoclast function (Baron et al., 1993). The failure of any of
these processes as a consequence of diminished ATP levels
could contribute to the observed loss of bone resorption
when Cox activity decreases. The fact that treating the cells
with the classical Cox inhibitor KCN or with the complex I
inhibitor rotenone or the complex III inhibitor myxothiazol
Figure 7. The effects of CT treatment on OCLs. (A) Change 
in Cox activity with time in OCLs treated with CT (10
 9 M). 
Cox activity in OCLs at the different time points is shown as a 
percentage of that in the cells at time 0. (B) c-Src kinase activity 
in OCLs treated with CT (10
 9 M) was measured by in vitro kinase 
assay using enolase as a substrate. (C) AxGFP- or AxCsk
KD-infected 
OCLs were incubated for 20 min in the presence or absence 
of CT (10
 9 M). cAMP production by the cells was measured 
as described in Materials and methods (n   8). There was no 
significant difference in CT-induced cAMP production by GFP-
expressing and Csk
KD-expressing OCLs. (D) AxGFP- or AxCsk
KD-
infected OCLs were incubated for 30 min in the presence or 
absence of CT (10
 9 M). Cox activity of the cells was measured 
as described in Materials and methods (n   8; *, P   0.01 
compared with untreated AxGFP-infected OCLs). (E) Purified OCLs 
infected with AxGFP or AxCsk
KD at an MOI of 100 were cultured 
on dentine for 12 h with increasing concentrations of CT. The 
values are means   SD (n   8; *, P   0.05 compared with 
untreated AxGFP-infected OCLs; **, P   0.01). (F) Double 
immunofluorescence staining of F-actin (red) and Csk (green) in 
OCLs infected with AxGFP or AxCsk
KD at an MOI of 100. Purified 
GFP- or Csk
KD-expressing OCLs were treated with or without CT 
(10
 9 M) for 1 h. Csk
KD expression prevented CT-induced disruption 
of actin rings.T
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also decreased bone resorption (unpublished data) further
demonstrates the sensitivity of osteoclasts to decreased oxi-
dative phosphorylation.
Promoting Cox activity is clearly not the only role of c-Src
that is important for osteoclast function. For example, we
have previously reported that c-Src forms a complex with
autophosphorylated Pyk2 on integrin stimulation (Sanjay et
al., 2001). Preventing the Pyk2–SrcSH2 interaction by ex-
pressing Pyk2 with a mutated SrcSH2-binding site inhibited
Src localization in adhesion structures, disrupted normal ac-
tin ring formation, and reduced the bone-resorbing activity
of OCLs (unpublished data), suggesting that Pyk2-depen-
dent recruitment of c-Src to adhesion structure of plasma
membrane is also required for osteoclast function. Thus, it
appears that c-Src plays several key roles in both mitochon-
dria and plasma membrane–related functions that are criti-
cally important for osteoclast activity.
In addition, we found that CT treatment also regulates
Cox activity in OCLs, but in a manner opposite that of
c-Src, consistent with the report by Yang et al. (1998) that
cAMP down-regulates Cox activity in CHO cells by induc-
ing the dissociation of the PKA RI  regulatory subunit from
the CoxVb. PKA has also been reported to either inhibit
(Vang et al., 2001) or activate (Schmitt and Stork, 2002)
c-Src, depending on the cells studied. However, we found in
the present work that c-Src kinase activity in osteoclasts re-
mained unchanged after CT treatment (Fig. 7 B). Thus,
CT’s effects on Cox activity, the osteoclast actin ring, and
bone-resorbing activity are apparently not mediated by a
change in c-Src activity, although the CT-induced inhibi-
tion of Cox and bone resorption were both reversed when
c-Src activity was artificially increased by expressing the
dominant-negative Csk
KD. Elucidating how CT and Src in-
teract in regulating Cox activity and bone resorption gener-
ally remains a topic of future research.
In this work, we demonstrated that Cox activity is not im-
portant for osteoclast survival. In spite of decreased Cox ac-
tivity and bone resorption, CT promotes osteoclast survival
in vitro (Selander et al., 1996). The enhanced survival of
CT-treated OCLs indicates that CT is activating specific sig-
naling events that antagonize OCL apoptosis. Because we
have previously reported that activating the Ras/ERK signal-
ing pathway markedly inhibits the spontaneous apoptosis of
OCLs (Miyazaki et al., 2000b), we examined the interaction
of CT-induced signaling and the Ras/ERK cascade in regu-
lating OCL survival. CT (10
 9 M) stimulated a rapid and
transient increase in ERK activity in OCLs (unpublished
data). The expression of a dominant-negative Ras (Ras
DN)
inhibited both basal ERK activity and the CT-induced acti-
vation of ERK in OCLs, and reversed the CT-induced in-
crease in osteoclast survival (unpublished data), indicating
that CT promotes osteoclast survival at least in part by acti-
vating ERK.
In the present paper, we showed that Src-induced Cox ac-
tivity is involved in bone-resorbing activity of osteoclasts,
but not in their survival. The pattern of responses to CT of-
fers several interesting insights into the mechanisms that reg-
ulate osteoclast bone-resorbing activity and apoptosis. First,
the fact that CT both inhibits bone resorption and protects
against apoptosis clearly indicates that inhibition of bone re-
sorption is not necessarily linked to apoptosis. It also pro-
vides further evidence of the importance of ERK in protect-
ing osteoclasts from apoptosis because the CT-induced
inhibition of Cox would be expected to promote apoptosis
in the absence of the simultaneous induction of ERK activ-
ity. Consistent with the observation that CT protects osteo-
clasts against apoptosis, coexpression of constitutively active
MEK1 and CoxIV antisense in OCLs promoted their sur-
vival (Fig. 6, D and E). Finally, the correlation between de-
creased bone resorption and decreased Cox activity together
with decreased apoptosis provides strong evidence that Cox
plays an important role in promoting bone resorption that is
independent of protecting the cells against apoptosis.
Although CT is used therapeutically for diseases charac-
terized by elevated bone resorption (i.e., osteoporosis,
Paget’s disease, and humoral hypercalcemia of malignancy),
its mechanism of action is still largely unknown. Our dem-
onstration that Cox activity is important for cytoskeletal or-
ganization and bone-resorbing activity of osteoclasts and
that CT causes Cox activity to decrease identifies a novel re-
sponse of the osteoclast to CT. This raises the possibility
that the inhibitory effect of CT on bone resorption may be
partly due to the down-regulation of Cox activity in mature
osteoclasts.
The finding that Cox activity is modulated by c-Src re-
veals a new and potentially important aspect of Src’s regula-
tory function. Upstream signaling elements could activate
mitochondrial c-Src to increase ATP generation, thereby
promoting cellular activity. The identification and charac-
terization of signaling cascades that induce Src-mediated cel-
lular metabolic activity present an interesting new avenue for
further elucidating Src’s role in regulating cell function.
Finally, the detection of c-Src (this paper) and Lyn (Salvi
et al., 2002) within mitochondria, and our data indicating
that c-Src phosphorylates and regulates Cox activity adds a
hitherto unexpected element to our understanding of the
regulation of bioenergetics. To our knowledge, this is the
first evidence of the importation of tyrosine kinases into mi-
tochondria or of a direct regulatory effect of tyrosine kinases
on the electron transport chain. Thus, it constitutes a major
change in the currently accepted paradigm of eukaryotic
bioenergetics. The presence of Src family kinases in mito-
chondria is the first evidence that endosymbiants can ac-
quire host-derived regulatory mechanisms during coevolu-
tion, and thus calls attention to a previously unappreciated
aspect of the evolution of eukaryotic bioenergetics that mer-
its further attention.
Materials and methods
Antibodies and chemicals
MEM,    modification ( MEM), DME, and FBS were purchased from
GIBCO BRL. Collagen was obtained from Nitta Gelatin Co. Bacterial colla-
genase and dispase were purchased from Calbiochem. Mouse monoclonal
anti-cathepsin D, anti-calnexin, anti-EEA1, anti-MEK1, and anti-Csk anti-
bodies were obtained from BD Biosciences. Dr. T. Vanaman (University of
Kentucky, Lexington, KY) provided anti-plasma membrane Ca
2  ATPase
(PMCA; Dean et al., 1997; Chen et al., 2001). Mouse monoclonal anti-Src
antibody (Ab-1) was purchased from Oncogene Research Products, anti-
avian-Src antibody from Upstate Biotechnology, anti-Golgi 58K antibody
from Sigma-Aldrich, anti-Bcl-2 antibody from Santa Cruz Biotechnology,
Inc., and anti-CoxI, -CoxII, -CoxIV, and -CoxVb antibodies from MolecularT
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Probes, Inc. Anti-cleaved caspase-3 antibody was purchased from New
England Biolabs, Inc. Both anti–mouse and anti–rabbit HRP-conjugated
secondary antibodies were obtained from Fisher Scientific.
Cells and cell cultures
HEK 293 cells were cultured in  MEM/10% FBS. SYF, Src  , and c-Src
cells were purchased from the American Type Culture Collection and cul-
tured in DME/10% FBS. OCLs were obtained from coculture of osteoblas-
tic cells and bone marrow cells in the presence of 10 nM 1 , 25 dihydroxy
vitamin D3 [1 ,25(OH)2D3], and 1  M prostaglandin E2 [PGE2]. For bio-
chemical assays, OCLs were purified as reported elsewhere (Tanaka et al.,
1998). In brief, the cocultured cells were washed with  MEM and treated
with 5 ml of  MEM containing 0.1% collagenase and 0.2% dispase for 10
min to remove osteoblastic cells. The purity of OCLs and their precursors
in the final preparation was  90%.
Constructs and gene transduction
Adenovirus vectors carrying Cox subunit IV antisense [AxCoxIV
AS] and ki-
nase-dead c-Src [K295 to M, AxSrc
KD] were constructed as reported previ-
ously (He et al., 1998). The recombinant adenovirus vector carrying wild-
type Csk [AxCsk
wt] or kinase-dead Csk [K222 to R, AxCsk
KD] genes were
described previously (Miyazaki et al., 2000a). Infection of OCLs with ade-
novirus vectors was performed after the method described previously
(Tanaka et al., 1998). In short, on d 4, when OCLs began to appear, mouse
cocultures were incubated for 1 h at 37 C with a small amount of  MEM
containing the recombinant adenoviruses at the desired MOI. Cells were
then washed twice with PBS and further incubated with  MEM containing
10% FBS, 10 nM 1 , 25(OH)2D3, and 1  M PGE2 at 37 C. Experiments
were performed 3 d after the infection.
Subcellular fractionation
Subcellular fractionation was performed using OptiPrep™ (Accurate
Chemical and Scientific Corporation) and ultracentrifugation as described
elsewhere (Wentz-Hunter et al., 2002). A discontinuous gradient was pre-
pared using 30, 25, 20, 15, and 10% OptiPrep™ solution. The post-
nuclear supernatant was overlaid onto the discontinuous gradient and
centrifuged at 100,000 g for 3 h at 4 C. The gradient was removed in 10
equal fractions collected from the top of the gradient.
Isolation of mitochondria
HEK 293 cells or purified OCLs were washed with PBS and resuspended in
buffer A [20 mM Hepes, pH 8.0, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA,
250 mM sucrose, 1 mM PMSF, 10  g/ml leupeptin, 10  g/ml aprotinin,
and 0.2 mM sodium orthovanadate] for 30 min on ice, and then Dounce
homogenized. Unbroken cells and nuclei were pelleted by centrifugation
at 1,500 g for 5 min. Supernatants were further centrifuged at 10,000 g for
30 min. Blue-native PAGE was performed as described previously (Schag-
ger and von Jagow, 1991). The mitochondrial pellets were solubilized in
1.5 M  -amino-n-caproic acid (Sigma-Aldrich), 50 mM Bistris/HCl, pH 7.0,
and 10  l of 10% n-dodecylmaltoside (Roche). Insoluble material was re-
moved by centrifugation for 20 min at 20,000 g. The supernatant was sup-
plemented with 5  l of sample buffer (5% Serva Blue G in 750 mM
 -amino-n-caproic acid), and electrophoresed through 4 to 12% poly-
acrylamide gradient gels. Strips of the first-dimension gel containing sepa-
rated protein complexes were cut out and incubated with 1% SDS and 1%
2-mercaptoethanol for 45 min at RT and subjected to Tricine/SDS-PAGE
for separation in the second dimension.
Immunogold labeling
Mitochondria-enriched preparations were fixed in 8% PFA in 0.25 M
Hepes, pH 7.4, for 4 d, washed in PBS, and pelleted in 10% fish skin gela-
tin. The gelatin-embedded pellets were infiltrated overnight with 2.3 M su-
crose at 4 C and frozen in liquid nitrogen. Ultrathin cryosections were pre-
pared using a microtome (Ultracut; Leica) with cryoattachment, and
transferred to formvar/carbon-coated specimen grids. Sections were incu-
bated in PBS and 1% fish skin gelatin containing rabbit polyclonal anti-Src
antibody (N-16 or SRC2; 1:50 dilution; Santa Cruz Biotechnology, Inc.) or
mouse monoclonal anti-CoxIV (1:50 dilution; Molecular Probes, Inc.).
Controls were incubated in PBS without primary antibody. After PBS
washes, antibody-labeled grids were incubated in rabbit anti–mouse anti-
body (1:50 dilution) for 30 min. After PBS washes, all sections were incu-
bated with PBS and 1% fish skin gelatin containing 10 nm protein A gold
conjugate (1:80 dilution; J. Slot, Utrecht, Holland) for 30 min, washed in
PBS, postfixed in 1% glutaraldehyde, and contrasted with 1.8% methyl
cellulose and 0.5% uranyl acetate. Sections were viewed and images were
recorded with a transmission electron microscope (model 410; Philips).
Proteinase K treatment
The mitochondrial fraction was treated with 50 ng/ml proteinase K (Sigma-
Aldrich) in buffer A without protease inhibitors in the absence or presence
of 0.5% Triton X-100 at RT for 30 min. The reaction was stopped by the
addition of 1 mM phenylmethylsulfonylfluoride, and was analyzed by
Western blotting using antibodies to c-Src, Bcl-2, and CoxVb.
Measurement of enzyme activities
Cox activity was measured as described elsewhere (Chrzanowska-Lightowl-
ers et al., 1993). Mitochondria-enriched fractions from mouse embryonic fi-
broblasts or purified OCLs were incubated with 0.01% saponin in water for
5 min at RT. 50  l of mitochondria solution was transferred to 96-well
plates and 100  l of substrate medium was added to each well to give a fi-
nal concentration of 4 mM 3,3  DAB-tetrachloride, 100  M reduced cyto-
chrome c, and 2  g/ml catalase in 100 mM Na phosphate, pH 7.0. 100 mg
cytochrome c in 2.5 ml of 100 mM sodium phosphate, pH 7.0, was re-
duced by addition of 5 mg ascorbic acid using a preequilibrated G25 M
Sephadex column. Immediately after addition of substrate medium, light
absorbance at 450 nm was measured for 30 min, and the amount of protein
on culture plates was quantified by the Bradford method. Cox activity of the
cells was expressed as the OD increase normalized to the amount of pro-
tein. The difference between groups was statistically evaluated by ANOVA.
NADH:ubiquinone oxidoreductase (Complex I) activity was assayed in
10 mM Tris/HCl buffer (pH 7.4) containing 50 mM KCl, 1 mM EDTA, 100
 g/ml soybean L- -phosphatidylcholine, 125  M NADH ( -form), 2 mM
KCN, and 300 nM antimycin A. Mitochondria were disrupted by freezing
and thawing 2–3 times, and were then added to the assay mix. 40  M
decylubiquinone was added, and the rate of disappearance of NADH was
monitored at 340 nm (Estornell et al., 1993; James et al., 1996). Complex I
activity of the cells was expressed as the OD decrease normalized to the
amount of protein.
In vitro kinase assay
Equal amounts of lysate protein (500  g) were incubated with 2  g anti-
Src antibody (Ab-1) for 1 h at 4 C, and the immune complexes were recov-
ered with protein G Sepharose (GIBCO BRL). The immune complexes
were washed three times with washing buffer and three times with kinase
buffer (20 mM Hepes-NaOH, pH 7.4, and 10 mM MgCl2). To examine the
kinase activity of c-Src, one half of the immunoprecipitated material was
used for in vitro kinase assay, and the other half for Western blotting anal-
ysis to ensure that an equal amount of c-Src protein was recovered by im-
munoprecipitation. In vitro kinase activity was assayed as previously re-
ported (Miyazaki et al., 2000a). In brief, the samples were resuspended in
60  l kinase buffer with 5  Ci  [
32P]ATP in the presence of 1  g acid-
treated enolase, then incubated for 20 min at 30 C. The reaction was
stopped by adding 20  l of 4  sample buffer (250 mM Tris-HCl, pH 6.8, 8
mM EDTA, 12% SDS, 500 mM 2-mercaptoethanol, 15% glycerol, and
0.01% bromophenol blue). Samples were then subjected to SDS-PAGE un-
der reducing condition, followed by autoradiography.
Pit formation assay
Functionally active OCLs were formed in cocultures performed on col-
lagen gel as described previously (Miyazaki et al., 2000b). In brief, primary
osteoblastic cells and bone marrow cells were cocultured in the presence
of 10 nM 1 , 25 (OH)2D3, and 1  M PGE2 on 6-cm culture dishes coated
with 0.2% collagen gel matrix. 3 d after the infection, OCLs were recov-
ered by digesting the collagen gel with 0.2% collagenase for 20 min at
37 C. Cells released from the dishes were collected by centrifugation at
250 g for 5 min and resuspended in 5 ml  MEM containing 10% FBS. An
aliquot of the crude OCL preparation was transferred onto dentine slices
and cultured for an additional 12 h. After 12 h of incubation, the medium
was removed and 1 M NH4OH was added to the wells for 5 min. Adherent
cells were removed from the dentine slices by ultrasonication, and the re-
sorption pits were visualized by staining for 2 min with 1% toluidine blue
and 1% sodium borate in PBS. The resorbed area was measured using an
image analysis system linked to a light microscope (Osteometrics). The dif-
ference between groups was statistically evaluated by ANOVA.
Survival of OCLs
OCL survival was measured as reported previously (Miyazaki et al.,
2000b). OCLs were purified 3 d after the infection, and some of the cul-
tures were subjected to TRAP staining. Cell viability/survival is expressed
as morphologically intact TRAP-positive multinucleated cells. Other cul-
tures were further incubated for the indicated times, and then the number
of living OCLs was determined. The number of viable cells remaining at
the different time points is shown as a percentage of the cells at time 0.T
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cAMP assay
AxGFP- or AxCsk
KD-infected OCLs were purified and incubated with 10
 9 M
CT for 20 min. The cells were then lysed and the cAMP was measured
using cAMP Biotrak™ Enzyme Immunoassay System (Amersham Bio-
sciences), according to the manufacturer’s instructions.
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